Clinical Trials in Forth Worth, Texas
1 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Summit Therapeutics780 enrolled202 locationsNCT06767514
Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
CancerBladder CancerImmunotherapy+1 more
Elephas2,000 enrolled8 locationsNCT07327489
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder CarcinomaEsophageal CarcinomaNon-small Cell Lung Cancer+13 more
Guardant Health, Inc.2,020 enrolled57 locationsNCT05059444